...d Non-Radioactive Translation Detection Systems al...zed in vitro. Using these systems, biotinylated ly...ns during translation, eliminating the need for la...amino acids. This biotinylated lysine is added to ...
Dulbecco's Phosphate Buffered Saline (DPBS) from Sigma-Aldrich
Illumina Standard Data Analysis Report from Asuragen, Inc.
... value of your microarray data using Asuragens bio...ed from consultation to extensive data analysis us...tise in combination with the Gene Expression Profi...ts., ,Normalization and basic statistical anal...
Biology Products:(Date:11/23/2009)..., BIRMINGHAM, Ala. A new study by University of ... body-mass index (BMI) and co-existing medical con...d survival observed among African-Americans compar...tudy is published online Nov. 23 in Cancer , a jo...ing indicates that although BMI and co-morbidity a...
(Date:11/23/2009)...HAMPAIGN, Ill. Two new studies reveal in unpreced... molecules to assemble new proteins and guide them... studies used molecular dynamics flexible fitting ...with two prominent molecular partners. , The fi... of Sciences , concerns the intimate signaling bet...
(Date:11/23/2009)...ORVALLIS, Ore. A string of recent discoveries abo...enewed interest in this multi-purpose nutrient, in...o are deficient in it, spurred research and even l...c." , On issues ranging from the health of your ...ven vulnerability to influenza, vitamin D is now s...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Fewer Shots Could Still Protect Kids From Pneumonia 50989 1Fewer Shots Could Still Protect Kids From Pneumonia 50989 2New Clues to Race Gap in Breast Cancer Outcomes 50984 1New Clues to Race Gap in Breast Cancer Outcomes 50984 2New Clues to Race Gap in Breast Cancer Outcomes 50984 3Video 3A Perot Systems Unveils Series of Healthcare Video Case Studies 50979 1Video 3A Perot Systems Unveils Series of Healthcare Video Case Studies 50979 2(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-FirstCa...ncedthatithasreceivednoticefrom,theNasdaqStockMark...ndedasofNovember30,2009andaForm25-NSEwillbefiledwi...ovedeCODE,scommonstock,fromlistingonNasdaq,unlesst...tionsPanel.Thecompanyhasfiledsuchanappeal,which,wi...
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-FirstCa...ncedtheapprovalofallofits,"firstday"motionsbytheU....kruptcyCourt").deCODElastweekfiledavoluntarypetiti...tcyCodewiththe,BankruptcyCourt. , Theordersis...tooperateitsbusinessduringtheChapter11proceedings....
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiola...tion(SFDA)hasapprovedthe,investigationalnewdrugapp...nnovativeinsulinformulationtotreatdiabetes.ThisIND...icalstudy. , Diabetesisadisordercharacteristi...ionsofdiabetesoftenresultinseveremicro-and,macro-v...
(Date:11/24/2009)... ,Primaryefficacyendpointhasbeenmetforpatientswit..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEterna...aglobalbiopharmaceuticalcompanyfocusedonendocrinet...tafromaPhase2studywithitstargetedcytotoxicpeptidec...vancedorrecurrentendometrialcancer.Inapersonalized...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4